GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Green Thumb Industries Inc (OTCPK:GTBIF) » Definitions » Forward Dividend Yield %

Green Thumb Industries (Green Thumb Industries) Forward Dividend Yield % : 0.00% (As of Jun. 01, 2024)


View and export this data going back to 1987. Start your Free Trial

What is Green Thumb Industries Forward Dividend Yield %?

As of today (2024-06-01), the Forward Annual Dividend Yield of Green Thumb Industries is 0.00%.

As of today (2024-06-01), the Trailing Annual Dividend Yield of Green Thumb Industries is 0.00%.

GTBIF's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.92
* Ranked among companies with meaningful Forward Dividend Yield % only.

Green Thumb Industries's Dividends per Share for the three months ended in Mar. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Green Thumb Industries's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Green Thumb Industries's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Green Thumb Industries's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Green Thumb Industries's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Green Thumb Industries's Forward Dividend Yield % falls into.



Green Thumb Industries Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Green Thumb Industries  (OTCPK:GTBIF) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Green Thumb Industries Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Green Thumb Industries's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Green Thumb Industries (Green Thumb Industries) Business Description

Traded in Other Exchanges
Address
325 West Huron Street, Suite 700, Chicago, IL, USA, 60654
Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 15 states and operates roughly 87 cannabis stores under the brand Rise. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to U.S. federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles and RYTHM.
Executives
Richard Reisin director 325 W. HURON STREET, SUITE 700, CHICAGO IL 60654
Hannah Scofield Buchan director 660 MADISON AVENUE, 14TH FLOOR, NEW YORK NY 10065
Ethan Nadelmann director 325 WEST HURON STREET, SUITE 700, CHICAGO IL 60654
Dawn Wilson Barnes director 325 WEST HURON STREET, SUITE 700, CHICAGO IL 60654
Bret Kravitz officer: GENERAL COUNSEL AND SECRETARY 325 WEST HURON STREET, SUITE 700, CHICAGO IL 60654
Jeffrey H Goldman director 325 W HURON STREET, SUITE 700, CHICAGO IL 60654
Richard A Drexler director 200 S MICHIGAN AVE, SUITE 1300, CHICAGO IL 60604
Dorri Mcwhorter director 6431 OAKTON STREET, C/O LIFEWAY FOODS, INC., MORTON GROVE IL 60053
Swati Mylavarapu director 325 W. HURON ST., SUITE 700, CHICAGO IL 60654
Mathew Faulkner officer: Chief Accounting Officer 325 W. HURON, SUITE 412, CHICAGO IL 60654
Beth Elaine Burk officer: General Counsel 325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654
Benjamin Kovler director, 10 percent owner, officer: Chairman & CEO 325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654
Armen Yemenidjian officer: President 325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654
Jennifer Dooley other: Chief Strategy Officer 325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654
Westley Moore director 325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654